A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus

NCT01792284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: LY2605541
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company